Medindia
Medindia LOGIN REGISTER
Advertisement

Harmony Biosciences Announces FDA Approval Of WAKIX® (Pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy

Thursday, August 15, 2019 General News
Advertisement
WAKIX represents the first and only non-scheduled treatment approved for patients with narcolepsy in the U.S.



Harmony (PRNewsfoto/Harmony Biosciences, LLC)

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close